<sup>18</sup>F-alfatide PET/CT may predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer.

Eur J Nucl Med Mol Imaging · 2016 · PMC5095164 · PMID 27631310

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantP < 0.001actually significant

There were highly significant correlations between SUV max , SUV peak , T/NT lung , T/NT blood and T/NT muscle of 18 F-alfatide PET/CT and the short-term outcomes assessed by RECIST ( P < 0.001) (Fig. 1 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.